Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05807854 · ClinicalTrials.gov registry record · NA
RSA Vs RCR for Massive RCTs
A NA study of Rotator Cuff Tears, sponsored by La Tour Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 2
- Study locations
NCT05807854: Recruiting NA study of Rotator Cuff Tears, sponsored by La Tour Hospital.
NCT05807854 is a NA study of Rotator Cuff Tears that is actively recruiting participants, run by La Tour Hospital. The registered enrollment target is 160 participants, below the 1,273-participant average among 20 other Rotator Cuff Tears trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05807854, a NA study of Rotator Cuff Tears, is actively recruiting participants, sponsored by La Tour Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 2
- Study locations
Study Summary
Different treatment options are available for massive or irreparable rotator cuff tears. An arthroscopic or an open repair approach is possible in the majority of cases and functional outcomes are improved, particularly when a complete arthroscopic repair can be achieved. However, the healing rate of massive rotator cuff tears after repair may remain low and failure of healing is associated with progression of arthritis. An alternative to arthroscopic or open repair is reverse shoulder arthroplasty which decreases pain and improves function, active shoulder elevation and quality of life. The primary goal of this prospective multicentric randomized study is to determine if there is a difference of functional outcomes between rotator cuff repair (RCR) repair and reverse shoulder arthroplasty (RSA).
Primary Outcome
American Shoulder and Elbow Surgeon (ASES) score. From 0 (worst) to 100 (best).
Conditions Studied
Interventions
- PROCEDURE Arthroscopy
- DEVICE Reverse Shoulder Arthroplasty
Study Locations (2)
Oregon
- Oregon Health & Science University - Portland
Canton of Geneva
- La Tour hospital - Meyrin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2027-03-01 |
| Phase | NA |
What NCT05807854 shows while recruiting
NCT05807854 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 1,273-participant average among 20 other Rotator Cuff Tears trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Rotator Cuff Tears appearing as the primary indexed condition, and to 2 interventions - of which Arthroscopy is the first listed.
NCT05807854 reports a single indexed study location in Oregon, Canton of Geneva.
Frequently Asked Questions
What is clinical trial NCT05807854 about?
NCT05807854 is a clinical study titled "RSA Vs RCR for Massive RCTs". Different treatment options are available for massive or irreparable rotator cuff tears. An arthroscopic or an open repair approach is possible in the majority of cases and functional outcomes are improved, particularly when a complete arthroscopic repair can be achieved. However, the healing rate o...
What is the current status of trial NCT05807854?
This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2023-03-01. Estimated completion is 2027-03-01.
What conditions does trial NCT05807854 study?
This clinical trial studies the following conditions: Rotator Cuff Tears.
What interventions are being tested in trial NCT05807854?
The interventions under investigation include: Arthroscopy (PROCEDURE), Reverse Shoulder Arthroplasty (DEVICE).
Who is sponsoring clinical trial NCT05807854?
This trial is sponsored by La Tour Hospital, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05807854 being conducted?
This trial has 2 study locations across Oregon, Canton of Geneva. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rotator Cuff Tears
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05807854's enrollment target sits among peer trials
160 6th of 20 higher than 14 of 20 other Rotator Cuff Tears trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rotator Cuff Tears trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
FiberLocker® System Augmentation of Rotator Cuff Repairs
RECRUITING · NA
-
InSpace Accelerated Rehabilitation Study
RECRUITING · NA
-
Prospective Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft Active Matrix (AM) vs. Standard of Care in Arthroscopic Rotator Cuff Repair
RECRUITING · NA
-
Innovating Physical Therapy: A Pilot Study on Band Connect's Impact on Compliance, Satisfaction, and Revenue
RECRUITING · NA
-
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
RECRUITING · NA
-
BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI